3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
3
Breast Neoplasms
3
Male Urogenital Diseases
2
Small Cell Lung Carcinoma
1
Polycystic Ovary Syndrome
1
Lymphoma, Follicular
1
Lymphedema
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Fibrosis
1
Erectile Dysfunction
1
Drug-Related Side Effects and Adverse Reactions
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
Amifostine
10
Cisplatin
8
Radiotherapy
7
Etoposide
6
Cyclophosphamide
4
Carboplatin
4
Paclitaxel
3
pegfilgrastim
2
camrelizumab
2
apatinib
2
Mitoxantrone
2
Filgrastim
2
Drug Therapy
2
Cytarabine
2
sodium thiosulfate
1
sargramostim
1
pazopanib
1
icotinib
1
glucarpidase
1
etoposide phosphate
1
denileukin diftitox
1
Vitamin E
1
Triptorelin Pamoate
1
Tocopherols
1
Thiotepa
1
Tegafur
1
Taxes
1
Surgical Procedures, Operative
1
Silymarin
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Drug-Related Side Effects and Adverse Reactions
×
Vitamin E
×
Clear all
NCT00002586
2020-05-15
13-Cis
University of Colorado, Denver
Phase 2
Completed
96 enrolled